Time Efficiency Comparison of Two IntraVitreal Injection Techniques
NCT04455399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2021-04-27
Summary
Prospective, single-center, randomized, clinical trial (RCT) comparing the time efficiency and safety of a single-use intravitreal injection (IVI) guide versus a traditional technique using a dual blade speculum among patients undergoing IVI for various indications.
Conditions
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Retinal Vein Occlusion With Macular Edema
- Uveitic Macular Edema
- Choroidal Neovascularization
Interventions
- DEVICE
-
Intravitreal injection guide (Malosa)
A single use, multifunction device will be used to push away an eyelid to expose injection site, indicate injection point about 4 millimeters from surgical limbus, and directs needle perpendicular to the ocular surface while limiting intraocular needle incursion
- DEVICE
-
Dual Blade Eyelid Speculum
A conventional dual blade eyelid speculum will be use to push away eyelids. A Castroviejo surgical caliper will be used to mark the injection site.
Sponsors & Collaborators
-
Peregrine Eye and Laser Institute
lead OTHER
Principal Investigators
-
Harvey S Uy, MD · Peregrine Eye and Laser Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-09
- Primary Completion
- 2021-01-09
- Completion
- 2021-01-09
Countries
- Philippines
Study Locations
More Related Trials
-
Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion
NCT01291121 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.
NCT02321839 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO
NCT03054766 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema
NCT00989989 ·Status: COMPLETED ·Phase: PHASE3
-
Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
NCT02169648 ·Status: UNKNOWN ·Phase: NA
-
Subfoveal Choroidal Thickness and Visual Acuity After Intravitreal Injection of Ranibizumab in Diabetic Retinopathy
NCT06173245 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD
NCT00058994 ·Status: COMPLETED ·Phase: PHASE3
-
601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)
NCT04667910 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-VEGF in Real-world
NCT05222633 ·Status: UNKNOWN
-
Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging
NCT03105609 ·Status: TERMINATED
-
To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema
NCT01846299 ·Status: COMPLETED ·Phase: PHASE3
-
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
NCT05662943 ·Status: COMPLETED
-
Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)
NCT01972789 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
NCT02358889 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
NCT01217944 ·Status: COMPLETED ·Phase: PHASE3
-
Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic Macula Edema
NCT06878573 ·Status: COMPLETED
-
Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment
NCT01823965 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
NCT01135914 ·Status: COMPLETED ·Phase: PHASE3
-
Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO
NCT02091505 ·Status: UNKNOWN ·Phase: NA
-
A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
NCT01277302 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
NCT01396083 ·Status: COMPLETED ·Phase: PHASE3
-
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study
NCT00687804 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
NCT01922102 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration
NCT01162746 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy
NCT01256632 ·Status: COMPLETED ·Phase: NA